Cardiovascular risk and acute coronary syndrome management in chronic kidney disease patients: a prospective observation study

Mobarok Hossen; Enamul Kabir Khan; Mohammad Nazmul Haq; Mohammad Saiful Islam; Shanaz Pervin

doi:10.18203/2320-6012.ijrms20243691

Authors

Mobarok Hossen Department of Cardiology, Eastern Medical College, Cumilla, Bangladesh
Enamul Kabir Khan Departemnt of Medicine, Sohid Taj Uddin Ahmed Medical College, Gazipur, Bangladesh
Mohammad Nazmul Haq Department of Cardiology, 250 Beded General Hospital, Chandpur, Bangladesh
Mohammad Saiful Islam Department of Anasthesia, 250 Beded General hospital, Chandpur, Bangladesh
Shanaz Pervin Departemnt of Gynaecology and Obstetrics, Central Medical College, Cumilla, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243691

Keywords:

Acute coronary syndrome, Chronic kidney disease, Coronary artery disease, Uremia

Abstract

Background: Chronic kidney disease (CKD) significantly elevates the risk of coronary artery disease (CAD) due to both traditional and uraemia-related risk factors, leading to accelerated atherosclerosis and increased cardiovascular events. This study aims to evaluate the clinical and therapeutic characteristics of CKD patients with ACS, assess CKD's impact on ACS severity and outcomes and identify effective management strategies for this high-risk group.

Methods: This prospective study included 104 ACS patients admitted across various medical centers in Cumilla, Bangladesh between June 2023 and June 2024. Data were collected on demographics, clinical history, diagnostics and therapeutic interventions, with rigorous ethical considerations and informed consent. Statistical analysis was conducted using descriptive statistics to explore the clinical and therapeutic characteristics of ACS in patients with CKD.

Results: The study examined a diverse patient group with an average age of 34.2 years, predominantly male (55.8%). Smoking was reported by 26.9%, with hypertension (38.5%) and diabetes (28.8%) being common. LVEF was normal in 50%, mildly reduced in 25% and moderately reduced in 25%. Chest pain was the most common symptom (26.9%). ACS patients with chronic kidney disease had higher complication rates, including reinfarction (27.9%), cerebrovascular events (21.2%) and an in-hospital mortality rate of 14.4%, underscoring the severity of their cardiovascular risks.

Conclusions: In conclusion, chronic kidney disease (CKD) markedly amplifies the risk of coronary artery disease (CAD) by combining traditional cardiovascular risk factors with those related to uraemia, resulting in heightened morbidity and mortality.

Metrics

Metrics Loading ...

References

Yamamoto S, Kon V. Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr. Opin. Nephrol. Hypertens. 2009;18:181–8.

Manea M, Marcu D, Pantea Stoian A. Heart failure with preserved ejection fraction and atrial fibrillation: A review. Rev Chim. 2018;69;4180–4.

Moisi MI, Rus M, Bungau S, Zaha DC, Uivarosan D, Fratila O, et al. Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics. Medicina (B Aires). 2020;8;56(3):118.

Maskey A, Sayami A, Pandey MR. Coronary artery disease : an emerging epidemic in NEPAL. J Nepal Med Assoc. 2003;1;42(146):122–4.

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the american heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology and epidemiology and prevention. Circulation. 2003;108:2154–69.

Go AS, Chertow GM, Fan D. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. New England J Med. 2004;351(13),1296-305.

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms and prevention. The Lancet. 2004;382(9889),339-52.

Carrero JJ, Stenvinkel P, Fellström B, et al. The impact of atherosclerosis on the cardiovascular system in chronic kidney disease: evidence for a dysfunctional cardio-renal connection. Kidney Int. 2005;68(1):62-75.

Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5):112-9.

Weiner DE, Tighiouart H, Amin MG. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307-15.

Stenvinkel P, Carrero JJ. Nephrology: Increased cardiovascular risk in chronic kidney disease: clinical implications. Nature Reviews Nephrol. 2012;8(7):368-70.

Levin A, Stevens P. Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance and a framework for moving forward. Kidney International, 2012;85(1):49-61.

Kovesdy CP, Lott EH. Management of cardiovascular risk in chronic kidney disease: recent advances and future challenges. Kidney International. 2012;81(12):1276-85.

KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2012;3(1):1-150.

Herzog CA, Asinger RW. Management of cardiovascular disease in chronic kidney disease: balancing the risk of coronary artery disease with the risk of adverse outcomes. J Am Soc Nephrol. 2011;22(11),1963-72.

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end stage kidney disease: A systematic review. Lancet. 2015;385(9981):1975–82.

Mohanan PP, Mathew R, Harikrishnan S, Krishnan MN, Zachariah G, Joseph J, et al. Presentation, management and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J. 2013;7;34(2):121–9.

Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87–165.

Farman MT, Sial JA, Khan NU, Rizvi SN, Saghir T, Zaman KS. Outcome of primary percutaneous coronary intervention at public sector tertiary care hospital in Pakistan. JPMA. 2011;1; 61(6):575.

Fox CS, Mutner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST segment elevation myocardial infarction in patients with chronic kidney disease: A report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry. Circulation. 2010;26;121(3):357–65.

Washam JB, Herzog CA, Beitelshees AL, Cohen MG, Henry TD, Kapur NK, et al. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome. Circulation. 2015;131(12):1123–49.

Iqbal F, Barkataki JC. Spectrum of acute coronary syndrome in North Eastern India – A study from a major center. Indian Heart J. 2016;68:128-31.